Perrigo exits infant-formula with sale to MeridianMade
New York-listed Perrigo said the divesture follows a strategic review, concluding a sale is the “best path forward for the business and its stakeholders”.
New York-listed Perrigo said the divesture follows a strategic review, concluding a sale is the “best path forward for the business and its stakeholders”.